Skip to main content
. 2015 Dec 30;129(3):753–761. doi: 10.1378/chest.129.3.753

Table 1.

Clinical Characteristics of 10 Patients With AIP*

Patient/Sex/Age, yr Smoking Status Fever RR, breaths/min APACHE II Score Pao2/Fio2 at SLBs Sx-Adm, d Adm-MV, d Adm-SLBx, d Adm-Steroid, d PEEP, cm H2O Vt/kg, mL Outcome (F/U Duration)
1/F/68 NS + 42 12 126.9 25 0 2 0 12 7.6 Died at 32 d
2/F/68 NS 32 9 93.3 21 5 7 7 10 8.9 Survived (75 mo)
3/M/60 CS + 32 13 287.3 2 1 3 1 8 7.7 Survived (78 mo)
4/M/70 ES + 36 10 196.2 4 0 4 3 8 7.4 Survived (62 mo)
5/M/57 CS + 36 18 147.0 4 1 6 8 16 6.4 Survived (60 mo)
6/M/38 CS + 44 10 100.5 9 4 5 4 12 7.9 Survived (59 mo)
7/M/63 CS + 40 11 231.2 5 1 2 4 10 6.0 Survived (48 mo)
8/F/70 CS + 38 12 82.6 21 1 3 3 14 6.1 Died at 18 d
9/F/73 NS + 40 11 134.2 10 0 3 3 10 6.1 Survived (28 mo)
10/M/51 CS + 34 15 116.0 34 3 9 10 12 6.6 Survived (12 mo)
*

M = male; F = female; NS = never smoker; ES = ex-smoker; CS = current smoker; RR = respiration rate; Sx-Adm = time interval from the onset of symptom to hospital admission; Adm-MV = time interval from admission to initiation of mechanical ventilation; Adm-SLBx = time interval from admission to surgical lung biopsy; Adm-Steroid = time interval from admission to the initiation of high-dose steroid therapy; MV = mechanical ventilation; F/U = follow up; Vt = tidal volume; + = yes; − = no.

Died due to progression of lung fibrosis 75 months later.